نتایج جستجو برای: ssri

تعداد نتایج: 1849  

2013
J. D. A. Olivier H. Åkerud H. Kaihola J. L. Pawluski A. Skalkidou U. Högberg I. Sundström-Poromaa

It has been estimated that 20% of pregnant women suffer from depression and it is well-documented that maternal depression can have long-lasting effects on the child. Currently, common treatment for maternal depression has been the selective serotonin reuptake inhibitor medications (SSRIs) which are used by 2-3% of pregnant women in the Nordic countries and by up to 10% of pregnant women in the...

Journal: :The journal of sexual medicine 2014
Ruziana Masiran Hatta Sidi Zahurin Mohamed Nur Elia Mohd Nazree Nik Ruzyanei Nik Jaafar Marhani Midin Srijit Das Suriati Mohamed Saini

INTRODUCTION Selective serotonin reuptake inhibitors (SSRIs) are known for their sexual side effects. Different SSRIs may affect different areas of sexual function at different rates. AIMS The study aimed to determine the prevalence of female sexual dysfunction (FSD), its clinical correlates, and association with 5HT2A (rs6311) single nucleotide polymorphisms (SNPs) in patients with major dep...

2009
Lars Henning Pedersen Tine Brink Henriksen Mogens Vestergaard Jørn Olsen Bodil Hammer Bech

OBJECTIVE To investigate any association between selective serotonin reuptake inhibitors (SSRIs) taken during pregnancy and congenital major malformations. DESIGN Population based cohort study. PARTICIPANTS 493 113 children born in Denmark, 1996-2003. MAIN OUTCOME MEASURE Major malformations categorised according to Eurocat (European Surveillance of Congenital Anomalies) with additional d...

Journal: :The Tohoku journal of experimental medicine 2007
Ahmet Mesut Onat Mehmet Akif Oztürk Levent Ozçakar Kemal Ureten Semra Ulusoy Kaymak Sedat Kiraz Ihsan Ertenli Meral Calgüneri

Familial Mediterranean Fever (FMF) is characterized by recurrent acute attacks of fever and serositis, and colchicine is the primary treatment. The pathogenesis of the disease has not been fully understood. Resistance to colchicine remains to be a problem in up to 30% of the patients and yet there seems to be no alternative treatment. In this study our objective was to investigate whether a sel...

Journal: :MMW - Fortschritte der Medizin 2016

Journal: :The American journal of psychiatry 1998
B Knutson O M Wolkowitz S W Cole T Chan E A Moore R C Johnson J Terpstra R A Turner V I Reus

OBJECTIVE The authors sought to test the causal hypothesis that serotonergic function modulates aspects of the normal spectrum of individual differences in affective experience and social behavior in humans. METHOD A selective serotonin reuptake inhibitor (SSRI), paroxetine, 20 mg/day (N = 26), or placebo (N = 25) was administered to normal volunteers in a double-blind manner for 4 weeks, and...

2015
Vahid Farnia Mehdi Shirzadifar Jalal Shakeri Mansour Rezaei Hafez Bajoghli Edith Holsboer-Trachsler Serge Brand

BACKGROUND A substantial disadvantage of psychopharmacological treatment of major depressive disorder (MDD) with selective serotonin-reuptake inhibitors (SSRIs) is the impact on sexual dysfunction. The aim of the present study was to investigate whether the oil of Rosa damascena can have a positive influence on SSRI-induced sexual dysfunction (SSRI-I SD) of male patients who are suffering from ...

2016
Tye Dawood David A. Barton Elisabeth A. Lambert Nina Eikelis Gavin W. Lambert

Although it is recognized that patients with major depressive disorder (MDD) are at increased risk of developing cardiovascular disease (CVD) the mechanisms responsible remain unknown. Endothelial dysfunction is one of the first signs of CVD. Using two techniques, flow-mediated dilatation in response to reactive hyperemia and laser Doppler velocimetry with iontophoresis, we examined endothelial...

Journal: :Journal of affective disorders 2014
Gerard E Bruder Jorge E Alvarenga Daniel Alschuler Karen Abraham John G Keilp David J Hellerstein Jonathan W Stewart Patrick J McGrath

BACKGROUND Executive dysfunction and psychomotor slowing in depressed patients have been associated with poor antidepressant clinical response, but little is known about the value of neurocognitive tests for differential prediction of response. METHODS This report presents new findings for 70 depressed patients tested on neurocogntive tests before receiving treatment with a SSRI (escitalopram...

2013
Christine DeLorenzo Lauren Delaparte Binod Thapa-Chhetry Jeffrey M. Miller J. John Mann Ramin V. Parsey

Pre-treatment differences in serotonergic binding between those who remit to antidepressant treatment and those who do not have been found using Positron Emission Tomography (PET). To investigate these differences, an exploratory study was performed using a second imaging modality, diffusion-weighted MRI (DW-MRI). Eighteen antidepressant-free subjects with Major Depressive Disorder received a 2...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید